BACKGROUND & OBJECTIVE
With the years of research and billions of dollars in treatment, why are we failing to significantly help with chronic pain? The authors of this review attribute the continued global burden of Musculoskeletal (MSK) pain in part to poor quality healthcare1. The treatment of pain is a global problem, and one without consistent application of the evidence provided from clinical practice guidelines (CPG). The aim of this review was to identify a common set of recommendations from high quality studies that can be applied to “a broad range of MSK conditions”2.
The systematic review was registered through The International Prospective Register of Systematic Reviews (PROSPERO). The review and analysis followed accepted procedures with multiple reviewers and followed the Appraisal of Guidelines for Research and Evaluation II (AGREE II). AGREE II has high construct validity (it measures what it says it measures) and reliability. Each included CPG was scored for: scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence. High quality CPGs had a score of 50% or higher on AGREE II.
Common recommendations from the 44 included studies included: